Recombinant Anti-Lunatic Fringe antibody [EPR10391(B)] (ab151699)


  • Product name

    Anti-Lunatic Fringe antibody [EPR10391(B)]
    See all Lunatic Fringe primary antibodies
  • Description

    Rabbit monoclonal [EPR10391(B)] to Lunatic Fringe
  • Host species

  • Tested applications

    Suitable for: WB, Flow Cytmore details
    Unsuitable for: ICC,IHC-P or IP
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide, corresponding to residues in Human Lunatic Fringe (UniProt: Q8NES3).

  • Positive control

    • PC12, HeLa and K562 cell lysates; K562 cells.
  • General notes



    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    This product is a recombinant rabbit monoclonal antibody.



Our Abpromise guarantee covers the use of ab151699 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 42 kDa.
Flow Cyt 1/10 - 1/100.

ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.


  • Application notes
    Is unsuitable for ICC,IHC-P or IP.
  • Target

    • Function

      Glycosyltransferase that initiates the elongation of O-linked fucose residues attached to EGF-like repeats in the extracellular domain of Notch molecules. Decreases the binding of JAGGED1 to NOTCH2 but not that of DELTA1. Essential mediator of somite segmentation and patterning.
    • Involvement in disease

      Defects in LFNG are the cause of spondylocostal dysostosis type 3 (SCDO3) [MIM:609813]. An autosomal recessive condition of variable severity associated with vertebral and rib segmentation defects. The main skeletal malformations include fusion of vertebrae, hemivertebrae, fusion of certain ribs, and other rib malformations. Deformity of the chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is a natural consequence of the malformation and leads to a dwarf-like appearance. As the thorax is small, infants frequently have respiratory insufficiency and repeated respiratory infections resulting in life-threatening complications in the first year of life.
    • Sequence similarities

      Belongs to the glycosyltransferase 31 family.
    • Post-translational

      A soluble form may be derived from the membrane form by proteolytic processing.
    • Cellular localization

      Golgi apparatus membrane.
    • Information by UniProt
    • Database links

    • Alternative names

      • 3-N-acetylglucosaminyltransferase lunatic fringe antibody
      • Beta-1 antibody
      • Beta-13-N-acetylglucosaminyltransferase lunatic fringe antibody
      • lfng antibody
      • LFNG_HUMAN antibody
      • O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase antibody
      • SCDO3 antibody
      see all


    • All lanes : Anti-Lunatic Fringe antibody [EPR10391(B)] (ab151699) at 1/1000 dilution

      Lane 1 : PC12 cell lysate
      Lane 2 : HeLa cell lysate
      Lane 3 : K562 cell lysate

      Lysates/proteins at 10 µg per lane.

      All lanes : Goat anti-rabbit HRP at 1/2000 dilution

      Predicted band size: 42 kDa

    • Flow cytometric analysis of permeabilized K562 cells labeling Lunatic Fringe with ab151699 at 1/10 dilution (red) compared to a nonspecific control antibody (green).


    ab151699 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab151699.
    Please use the links above to contact us or submit feedback about this product.

    For licensing inquiries, please contact

    Sign up